Screener
Icahn Enterprises IEP Pharma — Restructuring Charges
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Icahn Enterprises in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The source filing: Icahn Enterprises’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-090605
| Line item | Investment | Energy | Automotive | Food Packaging | Real Estate | Home Fashion | Pharma | Holding Company | Consolidated |
|---|---|---|---|---|---|---|---|---|---|
| Other expenses from operations | — | — | 124 | — | 23 | — | — | — | 147 |
| Dividend expense | 5 | — | — | — | — | — | — | — | 5 |
| Selling, general and administrative | 2 | 41 | 109 | 13 | 5 | 11 | 14 | 8 | 203 |
| Restructuring, net | — | — | — | 1 | — | — | 1 | — | 2 |
| Interest expense | 2 | 32 | — | 3 | — | — | — | 84 | 121 |
| 9 | 2,705 | 368 | 95 | 28 | 40 | 24 | 92 | 3,361 | |
| (Loss) income before income tax benefit | (312) | 40 | (14) | (5) | (1) | (2) | (7) | (85) | (386) |
| Income tax (expense) benefit | — | (6) | 4 | (1) | — | — | — | 1 | (2) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Icahn Enterprises's pharma — restructuring charges?
- Icahn Enterprises (IEP) reported pharma — restructuring charges of $1M in Q2 2026.
- What does pharma — restructuring charges mean?
- Captures one-time costs associated with reorganizing, downsizing, or streamlining operations within the pharmaceutical business segment. These charges often include severance, facility closures, or asset write-downs intended to improve long-term operational efficiency. Investors track this to understand the impact of strategic pivots on short-term profitability.
Ask your AI about Icahn Enterprises's pharma — restructuring charges.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude